Literature DB >> 15922299

Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells.

Hiroyuki Mizuguchi1, Tomomi Sasaki, Kenji Kawabata, Fuminori Sakurai, Takao Hayakawa.   

Abstract

Human mesenchymal stem cells (hMSCs) are considered a source of cells for regenerative medicine, and cell and gene therapy. Efficient gene transfer into hMSCs is essential for basic investigations into cellular differentiation and developmental biology, and for therapeutic applications in gene-modified regenerative medicine. In the present study, we optimized the transduction of hMSCs by means of fiber-modified adenovirus (Ad) vectors. Among the various types of Ad vectors tested, the polylysine modification of the C-terminal of the fiber knob most markedly improved the efficiency of hMSC transduction. At 300 vector particles per cell of polylysine-modified Ad vectors, more than 95% of the hMSCs expressed transgene. In this condition, polylysine-modified Ad vectors mediated 460-fold more transgene activity than the conventional Ad vectors. Ad vectors containing the Ad type 35 fiber or an Arg-Gly-Asp (RGD) peptide in the fiber knob mediated 130 or 16 times, respectively, the transgene activity mediated by the conventional Ad vectors. We also examined the efficiency of transduction into adipogenic-differentiated hMSCs. In this latter case, only Ad vectors containing the Ad type 35 fiber showed efficient gene expression. These results showed that fiber-modified Ad vectors could become a potent tool for basic research into, and the therapeutic application of, hMSCs and adipogenic-differentiated hMSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922299     DOI: 10.1016/j.bbrc.2005.05.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Human placenta mesenchymal stem cells expressing exogenous kringle1-5 protein by fiber-modified adenovirus suppress angiogenesis.

Authors:  Y Chu; H Liu; G Lou; Q Zhang; C Wu
Journal:  Cancer Gene Ther       Date:  2014-05-23       Impact factor: 5.987

2.  Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage.

Authors:  Cindy Tj van Velthoven; Luca Braccioli; Hanneke Ldm Willemen; Annemieke Kavelaars; Cobi J Heijnen
Journal:  Mol Ther       Date:  2013-10-31       Impact factor: 11.454

3.  Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.

Authors:  Cindy T J van Velthoven; R Ann Sheldon; Annemieke Kavelaars; Nikita Derugin; Zinaida S Vexler; Hanneke L D M Willemen; Mirjam Maas; Cobi J Heijnen; Donna M Ferriero
Journal:  Stroke       Date:  2013-03-28       Impact factor: 7.914

Review 4.  Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

Authors:  Catherine Tang; Pamela J Russell; Rosetta Martiniello-Wilks; John E J Rasko; Aparajita Khatri
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

5.  Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects.

Authors:  Q Li; K Kawamura; S Okamoto; H Fujie; M Numasaki; M Namba; M Nagata; H Shimada; H Kobayashi; M Tagawa
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

6.  Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.

Authors:  Yin Zhu; Ming Cheng; Zhen Yang; Chun-Yan Zeng; Jiang Chen; Yong Xie; Shi-Wen Luo; Kun-He Zhang; Shu-Feng Zhou; Nong-Hua Lu
Journal:  Drug Des Devel Ther       Date:  2014-12-09       Impact factor: 4.162

7.  Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus.

Authors:  Fuminori Sakurai; Nobuhiro Narii; Kyoko Tomita; Shinsaku Togo; Kazuhisa Takahashi; Mitsuhiro Machitani; Masashi Tachibana; Masaaki Ouchi; Nobuyoshi Katagiri; Yasuo Urata; Toshiyoshi Fujiwara; Hiroyuki Mizuguchi
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-02       Impact factor: 6.698

8.  Gold nanoparticle coatings as efficient adenovirus carriers to non-infectable stem cells.

Authors:  Yulan Hernandez; Rebeca González-Pastor; Carolina Belmar-Lopez; Gracia Mendoza; Jesus M de la Fuente; Pilar Martin-Duque
Journal:  RSC Adv       Date:  2019-01-10       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.